Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study by Cohen, Yael C., Magen, Hila, Lavi, Noa, Gatt, Moshe E., Chubar, Evgeni, Horowitz, Nethanel, Kreiniz, Natalia, Tadmor, Tamar, Trestman, Svetlana, Vitkon, Roy, Rouvio, Ory, Shvetz, Olga, Shaulov, Adir, Ziv-Baran, Tomer, Avivi, Irit

Get full text

Daratumumab Carfilzomib Lenalidomide Dexamethasone Provides Effective Salvage for Functionally and Cytogenetically High-Risk Myeloma Patients, Except Those Expressing Module-1 Tran... by Cohen, Yael C, Gatt, Moshe E, Luttwak, Efrat, Lavi, Noa, Ganzel, Chezi, Chubar, Evgeni, Rouvio, Ory, Vaxman, Iuliana, Pasvolsky, Oren, Ballan, Mouna, Tadmor, Tamar, Nemets, Anatoly, Jarchowsky, Osnat, Shvetz, Olga, Shpilberg, Ofer, Dally, Najib, Leiba, Merav, Weiner, Assaf, Zada, Mor, Wang, Shuang-Yin, Gur, Chamutal, Lowenton-Spier, Noa, Goor-Porges, Liron, Amit, Ido, Avivi, Irit

Get full text

Time to Progression Post-Induction Predicts Outcomes of Ixazomib Based Therapy for Relapsed/Refractory Myeloma: Real World Data from a Multi-Site Israeli Registry Study by Cohen, Yael C, Magen, Hila, Lavi, Noa, Gatt, Moshe E., Chubar, Evgeni, Kreiniz, Natalia, Tadmor, Tamar, Trestman, Svetlana, Vitkon, Roy, Rouvio, Ory, Shvetz, Olga, Shaulov, Adir, Avivi, Irit

Get full text

A Novel Therapy-Resistance Transcriptional Signature Based on Single Cell Analysis in Kydar Clinical Trial by Cohen, Yael C, Zada, Mor, Wang, Shuang-Yin, Bornstein, Chamutal, David, Eyal, Moshe, Adi, Li, Baoguo, Shlomi, Shir, Gatt, Moshe, Lavi, Noa, Ganzel, Chezi, Lutwak, Efrat, Rouvio, Ory, Vaxman, Iuliana, Pasvolsky, Oren, Ballan, Mouna, Tadmor, Tamar, Nemets, Anatoly, Jarchowcky Dolberg, Osnat, Chober, Yevgeny, Shvetz, Olga, Leiba, Merav, Shpilberg, Ofer, Deli, Nagib, Avivi, Irit, Weiner, Assaf, Amit, Ido

Get full text

Clinical Benefit and Improvement of Mitochondrial Function in Low Risk Myelodysplastic Syndrome Treated By Combination Ultra Coenzyme Q10 and L-Carnitine by Filanovsky, Kalman, Haran, Michal, Mirkin, Vita, Braester, Andrei, Shvetz, Olga, Stanevsky, Anfisa, Sigler, Erica, Votinov, Ekaterina, Zaltsman-Amir, Yehudit, Gross, Atan, Shvidel, Lev

Get full text

Real-Life Data on the Outcome of Daratumomab-Refractory Myeloma Patients: Multi-Center Experience by Benyamini, Noam, S, Adir, Gatt, Moshe E., Cohen, Yael C, Avivi, Irit, Trestman, Svetlana, Shvetz, Olga, Tadmor, Tamar, Dally, Najib, Chober, Yevgeny, Magen, Hila, Ganzel, Chezi, Jarchowcky Dolberg, Osnat, Suriu, Celia, Lavi, Noa

Get full text

CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma by Lewinsky, Hadas, Gunes, Emine G, David, Keren, Radomir, Lihi, Kramer, Matthias P, Pellegrino, Bianca, Perpinial, Michal, Chen, Jing, He, Ting-Fang, Mansour, Anthony G, Teng, Kun-Yu, Bhattacharya, Supriyo, Caserta, Enrico, Troadec, Estelle, Lee, Peter, Feng, Mingye, Keats, Jonathan, Krishnan, Amrita, Rosenzweig, Michael, Yu, Jianhua, Caligiuri, Michael A, Cohen, Yosef, Shevetz, Olga, Becker-Herman, Shirly, Pichiorri, Flavia, Rosen, Steven, Shachar, Idit

Get full text

Kydar Multicenter Trial of Quadruple Regimen for Induction Resistant Myeloma Combined with Translational Single-Cell Analysis Identifies Potential Drivers of Advanced Resistance, I... by Cohen, Yael C, Zada, Mor, Gatt, Moshe E., Lavi, Noa, Ganzel, Chezi, Wang, Shuang-Yin, Weiner, Assaf, Ledergor, Guy, Chubar, Evgeni, Rouvio, Ory, Vaxman, Iuliana, Ballan, Mouna, Tadmor, Tamar, Nemets, Anatoly, Jarchowcky Dolberg, Osnat, Shvetz, Olga, Shpilberg, Ofer, Deli, Nagib, Avivi, Irit, Amit, Ido

Get full text

Real-Life Experience of Nivolumab in Heavily Pretreated Relapsed and Refractory Classical Hodgkin Lymphoma by Benjamini, Ohad, Lavie, David, Dann, Eldad J, Perry, Chava, Rouvio, Ory, Shvetz, Olga, Nemets, Anatoly, Perets, Ruth, Saban, Revital, Shimoni, Avichai, Ben-Yehuda, Dina, Nagler, Arnon, Avigdor, Abraham

Get full text

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma by Trakhtenbrot, Luba, Duek, Adrian, Amariglio, Ninette, Avigdor, Abraham, Benyamini, Noam, Hardan, Izhar, Zilbershatz, Itay, Ganzel, Chezi, Shvetz, Olga, Leiba, Ronit, Izak, Marina, Ziv, Cohen, Rozic, Gabriela, Nagler, Arnon, Leiba, Merav

Get full text